A leading urologist at Sunway Medical Centre has raised alarm about the delayed diagnosis of kidney cancer in Malaysia, revealing that 47 per cent of cases are identified only after the disease has progressed to late stages. Dr Christopher Lee Kheng Siang, a consultant urologist and robotic surgeon, emphasized that the disease's deceptively quiet progression—where early tumours typically produce no warning signs—makes preventive screening the only reliable pathway to catching this malignancy when cure rates remain highest.
Kidney cancer, clinically termed Renal Cell Carcinoma, presents a paradox common to many cancers: it is remarkably curable in its initial phases yet frequently becomes intractable once symptoms finally manifest. Dr Lee explained that early-stage tumours often develop silently within the kidney, escaping detection until they are discovered incidentally during routine imaging studies performed for unrelated reasons. This invisible progression means that by the time patients experience noticeable symptoms—such as flank pain, abdominal swelling, or haematuria—the cancer has typically already advanced significantly, limiting treatment options to palliative approaches aimed at extending survival rather than achieving cure.
The symptoms that eventually prompt medical attention tend to emerge only after tumours achieve considerable size. Patients may then report pain in the abdomen or lower back, visible swelling in the abdomen, or blood appearing in urine. In more aggressive cases, systemic manifestations such as unexplained fatigue, loss of appetite, and weight loss become apparent. These delayed warning signs explain why such a substantial proportion of Malaysian kidney cancer patients present with advanced disease, as the absence of early symptoms means many cancers grow unchecked for months or even years before being detected.
Dr Lee outlined the diagnostic pathway that follows initial suspicion of kidney pathology. When a kidney tumour or questionable cyst is identified—typically through incidental findings on ultrasound during health screening—patients are referred to a urologist for definitive evaluation. The standard confirmatory test involves a contrast-enhanced computed tomography scan of the kidneys and urinary tract, which achieves diagnostic accuracy of 95 to 99 per cent in identifying malignant lesions. Notably, biopsies are rarely necessary before treatment commences, allowing patients to proceed swiftly from diagnosis to intervention without unnecessary delays.
Surgical intervention forms the cornerstone of kidney cancer treatment, particularly for early-stage disease where complete cure remains achievable. The specific surgical approach depends fundamentally on tumour characteristics, particularly size and anatomical location. For smaller or favourably positioned tumours, partial nephrectomy—removing only the affected portion while preserving healthy kidney tissue—has become the preferred approach whenever technically feasible. This kidney-sparing strategy holds particular significance for younger patients who may require their kidney function over decades, patients with only one functioning kidney, and those at elevated risk of developing chronic kidney disease later in life.
The evolution of surgical technique has fundamentally transformed kidney cancer management over recent decades. Traditional open surgery, which involved large incisions and extended recovery periods, has progressively been superseded by laparoscopic and robotic-assisted approaches that accomplish the same therapeutic objectives through smaller portal incisions. Laparoscopic nephrectomy now represents the gold standard for larger kidney tumours unsuitable for nephron-sparing techniques, reserving open surgery for the most anatomically complex cases that cannot be safely navigated through minimally invasive means. These less invasive approaches deliver substantial benefits: reduced postoperative pain, shortened hospitalisation, accelerated recovery, and diminished trauma to surrounding tissues.
Robotic-assisted surgery represents a particularly significant advancement, enabling surgeons to perform intricate kidney-preserving operations that would previously have necessitated complete kidney removal. Dr Lee clarified an important misconception: the robotic system operates entirely under direct surgeon control, with no autonomous or artificial intelligence components directing surgical manoeuvres. Instead, the technology functions as an extension of the surgeon's own hands, providing a three-dimensional, high-definition magnified view of the surgical field combined with precision instruments that faithfully reproduce the surgeon's hand movements and gestures. This capability allows surgeons to attempt complex partial nephrectomies with confidence, significantly expanding the population of patients who can undergo kidney-preserving treatment.
The implications of these surgical advances extend beyond technical capability to directly impact patients' long-term quality of life and functional outcomes. Preserving kidney tissue whenever possible maintains renal function and reduces the subsequent risk of progressive chronic kidney disease, which represents a major source of morbidity in many cancer survivors. For Malaysian patients, where chronic kidney disease already represents a significant health burden, the ability to treat kidney cancer while maximizing preserved kidney function carries particular clinical and public health significance.
Dr Lee emphasised that kidney cancer represents a highly curable malignancy when identified early, making the case compellingly for regular health screening among apparently well individuals. The silent nature of early disease means that waiting for symptoms to develop—the approach many Malaysians unconsciously adopt—virtually guarantees late-stage diagnosis with its attendant poor prognosis. Comprehensive annual health screening, encompassing abdominal imaging to visualise the kidneys, represents the only dependable strategy for early detection. For Malaysian patients who feel entirely well and experience no symptoms, undertaking regular health screening can literally be life-altering, potentially shifting their diagnosis from an incurable late-stage disease to a highly curable early-stage malignancy treated through minimally invasive techniques that preserve both kidney function and quality of life.
